Madagascar hissing cockroach gains attention as a research model
Bottom line
Madagascar hissing cockroach gains attention as a research model
A review in Animals argues that the Madagascar hissing cockroach, Gromphadorhina portentosa, is emerging as a practical invertebrate model for bioscience research as pressure grows to reduce vertebrate animal use. The authors, Maria Vittoria Varoni, Filomena Dessì, and Elena Baralla, point to the species’ relatively large size, ease of laboratory maintenance and breeding, longevity, physiological resilience, and tolerance for handling as features that make it useful for experimental work. The paper also fits into a broader 3Rs conversation — replacement, reduction, and refinement — as U.S. Public Health Service policy applies to live vertebrate animals, while the EU’s Directive 2010/63/EU covers vertebrates and cephalopods, but not insects such as cockroaches. (grants.nih.gov)
Why it matters: For veterinary professionals, the review is a reminder that invertebrate medicine and invertebrate research are becoming more relevant, not less. G. portentosa is already familiar in classrooms, zoological collections, museums, laboratories, and as an exotic companion species, and veterinary pathologists have noted growing clinical interest in invertebrate medicine. Recent work from some of the same researchers also suggests the species may be useful for pain research: a 2026 study found gabapentin produced antinociceptive effects in G. portentosa in two thermal assays, supporting its potential as a non-vertebrate in vivo screening model. That could matter for preclinical workflows, comparative physiology, and welfare discussions around how invertebrates are housed, handled, and euthanized in research settings. (journals.sagepub.com)
What to watch: Expect more validation studies testing whether cockroach data can reliably predict findings in vertebrate models, especially in pain, infection, physiology, and toxicology research. (pubmed.ncbi.nlm.nih.gov)
Key facts
- Species
- Madagascar hissing cockroach (*Gromphadorhina portentosa*)
- Article type
- Review in *Animals*
- Research role
- Emerging invertebrate model for bioscience research
- Why it is useful
- Large, easy to maintain and breed, long-lived, physiologically robust, and tolerant for handling
- Regulatory context
- U.S. Public Health Service policy applies to live vertebrate animals; EU Directive 2010/63/EU covers vertebrates and cephalopods, not insects
- Existing uses
- Classrooms, zoos, museums, research laboratories, and private collections
- Pain study
- April 2026 study found gabapentin had antinociceptive effects in hot plate and hot box escape testing
- Potential application
- Non-vertebrate in vivo model for pain studies and screening analgesic compounds
A new review in Animals makes the case that the Madagascar hissing cockroach, Gromphadorhina portentosa, deserves more attention as an invertebrate model in bioscience research, reflecting a wider push to find practical alternatives to vertebrate animal use. The authors describe the species as especially workable in laboratory settings because it is large enough for manipulation and sampling, relatively easy to maintain and breed, long-lived, and physiologically robust. (pmc.ncbi.nlm.nih.gov)
That argument lands at a time when the research community is under sustained ethical and regulatory pressure to apply the 3Rs. In the U.S., NIH’s Office of Laboratory Animal Welfare says Public Health Service policy governs the humane care and use of live vertebrate animals in PHS-supported work. In the EU, Directive 2010/63/EU applies to live non-human vertebrates and cephalopods. In practical terms, that means insects occupy a different regulatory space from traditional mammalian lab species, helping explain why interest in insect models continues to grow. (grants.nih.gov)
The Madagascar hissing cockroach is not a new organism in science, but its use is broadening. Earlier literature has described it as an alternative non-mammalian model for studies of virulence, pathogenesis, innate immune response, and drug efficacy. Other published work has examined its cardiac physiology, behavior, locomotion, and pathology, underscoring that the species is experimentally tractable across multiple domains rather than for a single niche application. Veterinary pathology literature also notes that these cockroaches are commonly kept in classrooms, zoos, museums, research laboratories, and private collections, which gives veterinarians another reason to pay attention to the species. (pmc.ncbi.nlm.nih.gov)
One notable sign that this model is moving beyond theory came in April 2026, when several of the same researchers reported that gabapentin showed antinociceptive effects in G. portentosa using hot plate and hot box escape testing. The investigators concluded that the cockroach could serve as a suitable non-vertebrate in vivo model for pain studies and for screening other analgesic compounds. That finding doesn’t make the species a replacement for vertebrate models in every setting, but it does suggest that at least some pharmacology questions may be explored earlier, and with fewer vertebrate animals, than has traditionally been possible. (pubmed.ncbi.nlm.nih.gov)
Industry reaction specific to this review was limited in public sources, but adjacent commentary points in the same direction. A 2026 review in Molecular Cancer said international regulations generally exempt invertebrate models from animal-use legislation, while a 2023 Animals paper on welfare assessment in captive cockroaches argued that invertebrate welfare is gaining attention as insect use expands. Together, those signals suggest the field is evolving on two tracks at once: more enthusiasm for invertebrates as research tools, and more scrutiny of how those animals are managed. (link.springer.com)
Why it matters: For veterinary professionals, this is less about cockroaches specifically than about where biomedical research and animal welfare oversight may be heading. As insect models become more common, veterinarians working in laboratory animal medicine, zoological medicine, pathology, and exotics may increasingly be asked to advise on husbandry, health monitoring, anesthesia, euthanasia, and welfare assessment for species that historically received less formal attention. The veterinary literature already reflects that shift, with recent work addressing pathology in captive G. portentosa and broader questions around invertebrate euthanasia standards. (journals.sagepub.com)
There are still important limits. Invertebrate models cannot fully replicate vertebrate immunology, neurobiology, or drug metabolism, and regulatory acceptance of 3R models has historically been slower than scientific enthusiasm. So the likely near-term role for G. portentosa is as a complementary model: useful for mechanism studies, early screening, teaching, and some welfare-conscious replacement strategies, but not a wholesale stand-in for vertebrate research. That’s an inference based on the current literature and regulatory context, rather than a direct claim from one source. (sciencedirect.com)
What to watch: The next step is validation — more head-to-head studies asking when findings in G. portentosa track with vertebrate data, and whether institutions begin formalizing welfare, handling, and review standards for insect research as use expands. (pubmed.ncbi.nlm.nih.gov)